FDA Approved: SUNITINIB MALATE — Original Application (Novugen Pharma (USA) LLC.)

View source ↗

Summary

FDA approves a generic version of sunitinib malate from Novugen Pharma (USA) LLC under an Original Application (ANDA 218012).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Stromal Tumor
• Pancreatic Neuroendocrine Tumor
• Renal Cell Carcinoma

Drugs mentioned

• Sunitinib malate (sunitinib malate)

Snippet

ORIG AP for SUNITINIB MALATE (SUNITINIB MALATE)